With respect to the circulating IGF-1 concentration and lung cancer risk, initial meta-analysis has shown that it was at no significantly increased risk with the OR of 1.047(95% CI:[0.802,1.367], P = 0.736) for the highest vs. lowest levels of IGF-1 (Fig. 2A). This evidence concerns the gene IGF1 and lung carcinoma.